nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—EBP—Azacitidine—Gemcitabine—lung cancer	0.0105	1	CbGdCrCtD
Pentazocine—Hepatic function abnormal—Doxorubicin—lung cancer	0.00158	0.00179	CcSEcCtD
Pentazocine—Pruritus—Topotecan—lung cancer	0.00157	0.00178	CcSEcCtD
Pentazocine—Anaphylactic shock—Irinotecan—lung cancer	0.00157	0.00178	CcSEcCtD
Pentazocine—Feeling abnormal—Vinorelbine—lung cancer	0.00157	0.00178	CcSEcCtD
Pentazocine—Diarrhoea—Vinblastine—lung cancer	0.00157	0.00178	CcSEcCtD
Pentazocine—Dysgeusia—Etoposide—lung cancer	0.00157	0.00178	CcSEcCtD
Pentazocine—Pruritus—Erlotinib—lung cancer	0.00156	0.00176	CcSEcCtD
Pentazocine—Shock—Irinotecan—lung cancer	0.00154	0.00175	CcSEcCtD
Pentazocine—Muscle spasms—Etoposide—lung cancer	0.00154	0.00174	CcSEcCtD
Pentazocine—Dysgeusia—Paclitaxel—lung cancer	0.00154	0.00174	CcSEcCtD
Pentazocine—Anaphylactic shock—Gemcitabine—lung cancer	0.00153	0.00173	CcSEcCtD
Pentazocine—Diarrhoea—Topotecan—lung cancer	0.00152	0.00173	CcSEcCtD
Pentazocine—Irritability—Methotrexate—lung cancer	0.00152	0.00172	CcSEcCtD
Pentazocine—Hyperhidrosis—Irinotecan—lung cancer	0.00152	0.00172	CcSEcCtD
Pentazocine—Dizziness—Vinblastine—lung cancer	0.00151	0.00172	CcSEcCtD
Pentazocine—Muscle spasms—Paclitaxel—lung cancer	0.00151	0.00171	CcSEcCtD
Pentazocine—Diarrhoea—Erlotinib—lung cancer	0.00151	0.00171	CcSEcCtD
Pentazocine—Anorexia—Irinotecan—lung cancer	0.0015	0.0017	CcSEcCtD
Pentazocine—Vision blurred—Paclitaxel—lung cancer	0.00148	0.00168	CcSEcCtD
Pentazocine—Hyperhidrosis—Gemcitabine—lung cancer	0.00148	0.00168	CcSEcCtD
Pentazocine—Visual impairment—Docetaxel—lung cancer	0.00147	0.00167	CcSEcCtD
Pentazocine—Dizziness—Topotecan—lung cancer	0.00147	0.00167	CcSEcCtD
Pentazocine—Tremor—Paclitaxel—lung cancer	0.00147	0.00167	CcSEcCtD
Pentazocine—Hypotension—Irinotecan—lung cancer	0.00147	0.00166	CcSEcCtD
Pentazocine—Anorexia—Gemcitabine—lung cancer	0.00146	0.00165	CcSEcCtD
Pentazocine—Vomiting—Vinblastine—lung cancer	0.00146	0.00165	CcSEcCtD
Pentazocine—Dizziness—Erlotinib—lung cancer	0.00146	0.00165	CcSEcCtD
Pentazocine—Erythema multiforme—Docetaxel—lung cancer	0.00144	0.00164	CcSEcCtD
Pentazocine—Agitation—Paclitaxel—lung cancer	0.00144	0.00163	CcSEcCtD
Pentazocine—Vertigo—Etoposide—lung cancer	0.00144	0.00163	CcSEcCtD
Pentazocine—Headache—Vinblastine—lung cancer	0.00143	0.00163	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.00143	0.00162	CcSEcCtD
Pentazocine—Hypotension—Gemcitabine—lung cancer	0.00143	0.00162	CcSEcCtD
Pentazocine—Anaphylactic shock—Cisplatin—lung cancer	0.00142	0.00162	CcSEcCtD
Pentazocine—Insomnia—Irinotecan—lung cancer	0.00142	0.00161	CcSEcCtD
Pentazocine—Flushing—Docetaxel—lung cancer	0.00142	0.00161	CcSEcCtD
Pentazocine—Vomiting—Topotecan—lung cancer	0.00141	0.0016	CcSEcCtD
Pentazocine—Paraesthesia—Irinotecan—lung cancer	0.00141	0.0016	CcSEcCtD
Pentazocine—Vertigo—Paclitaxel—lung cancer	0.00141	0.0016	CcSEcCtD
Pentazocine—Syncope—Paclitaxel—lung cancer	0.00141	0.00159	CcSEcCtD
Pentazocine—Loss of consciousness—Etoposide—lung cancer	0.00141	0.00159	CcSEcCtD
Pentazocine—Hypersensitivity—Vinorelbine—lung cancer	0.0014	0.00159	CcSEcCtD
Pentazocine—Dermatitis—Topotecan—lung cancer	0.0014	0.00159	CcSEcCtD
Pentazocine—Vomiting—Erlotinib—lung cancer	0.0014	0.00159	CcSEcCtD
Pentazocine—Dyspnoea—Irinotecan—lung cancer	0.0014	0.00159	CcSEcCtD
Pentazocine—Somnolence—Irinotecan—lung cancer	0.00139	0.00158	CcSEcCtD
Pentazocine—Headache—Topotecan—lung cancer	0.00139	0.00158	CcSEcCtD
Pentazocine—Tachycardia—Cisplatin—lung cancer	0.00139	0.00158	CcSEcCtD
Pentazocine—Dermatitis—Erlotinib—lung cancer	0.00139	0.00157	CcSEcCtD
Pentazocine—Insomnia—Gemcitabine—lung cancer	0.00138	0.00157	CcSEcCtD
Pentazocine—Hypertension—Etoposide—lung cancer	0.00138	0.00157	CcSEcCtD
Pentazocine—Headache—Erlotinib—lung cancer	0.00138	0.00156	CcSEcCtD
Pentazocine—Loss of consciousness—Paclitaxel—lung cancer	0.00138	0.00156	CcSEcCtD
Pentazocine—Diplopia—Doxorubicin—lung cancer	0.00138	0.00156	CcSEcCtD
Pentazocine—Hyperhidrosis—Cisplatin—lung cancer	0.00138	0.00156	CcSEcCtD
Pentazocine—Paraesthesia—Gemcitabine—lung cancer	0.00137	0.00156	CcSEcCtD
Pentazocine—Chills—Docetaxel—lung cancer	0.00137	0.00155	CcSEcCtD
Pentazocine—Asthenia—Vinorelbine—lung cancer	0.00137	0.00155	CcSEcCtD
Pentazocine—Decreased appetite—Irinotecan—lung cancer	0.00136	0.00155	CcSEcCtD
Pentazocine—Dyspnoea—Gemcitabine—lung cancer	0.00136	0.00154	CcSEcCtD
Pentazocine—Eosinophilia—Methotrexate—lung cancer	0.00136	0.00154	CcSEcCtD
Pentazocine—Nausea—Vinblastine—lung cancer	0.00136	0.00154	CcSEcCtD
Pentazocine—Somnolence—Gemcitabine—lung cancer	0.00136	0.00154	CcSEcCtD
Pentazocine—Anorexia—Cisplatin—lung cancer	0.00136	0.00154	CcSEcCtD
Pentazocine—Hypertension—Paclitaxel—lung cancer	0.00135	0.00153	CcSEcCtD
Pentazocine—Pruritus—Vinorelbine—lung cancer	0.00135	0.00153	CcSEcCtD
Pentazocine—Constipation—Irinotecan—lung cancer	0.00134	0.00152	CcSEcCtD
Pentazocine—Hypotension—Cisplatin—lung cancer	0.00133	0.00151	CcSEcCtD
Pentazocine—Face oedema—Doxorubicin—lung cancer	0.00133	0.00151	CcSEcCtD
Pentazocine—Decreased appetite—Gemcitabine—lung cancer	0.00133	0.00151	CcSEcCtD
Pentazocine—Nausea—Topotecan—lung cancer	0.00132	0.0015	CcSEcCtD
Pentazocine—Abdominal discomfort—Methotrexate—lung cancer	0.00132	0.00149	CcSEcCtD
Pentazocine—Confusional state—Etoposide—lung cancer	0.00132	0.00149	CcSEcCtD
Pentazocine—Constipation—Gemcitabine—lung cancer	0.00131	0.00148	CcSEcCtD
Pentazocine—Nausea—Erlotinib—lung cancer	0.00131	0.00148	CcSEcCtD
Pentazocine—Dry mouth—Paclitaxel—lung cancer	0.00131	0.00148	CcSEcCtD
Pentazocine—Anaphylactic shock—Etoposide—lung cancer	0.00131	0.00148	CcSEcCtD
Pentazocine—Diarrhoea—Vinorelbine—lung cancer	0.0013	0.00148	CcSEcCtD
Pentazocine—Dysgeusia—Docetaxel—lung cancer	0.0013	0.00148	CcSEcCtD
Pentazocine—Feeling abnormal—Irinotecan—lung cancer	0.00129	0.00147	CcSEcCtD
Pentazocine—Confusional state—Paclitaxel—lung cancer	0.00129	0.00146	CcSEcCtD
Pentazocine—Anaphylactic shock—Paclitaxel—lung cancer	0.00128	0.00145	CcSEcCtD
Pentazocine—Paraesthesia—Cisplatin—lung cancer	0.00128	0.00145	CcSEcCtD
Pentazocine—Muscle spasms—Docetaxel—lung cancer	0.00128	0.00145	CcSEcCtD
Pentazocine—Tachycardia—Etoposide—lung cancer	0.00127	0.00144	CcSEcCtD
Pentazocine—Dyspnoea—Cisplatin—lung cancer	0.00127	0.00144	CcSEcCtD
Pentazocine—Hyperhidrosis—Etoposide—lung cancer	0.00126	0.00143	CcSEcCtD
Pentazocine—Feeling abnormal—Gemcitabine—lung cancer	0.00126	0.00143	CcSEcCtD
Pentazocine—Shock—Paclitaxel—lung cancer	0.00126	0.00143	CcSEcCtD
Pentazocine—Dizziness—Vinorelbine—lung cancer	0.00126	0.00143	CcSEcCtD
Pentazocine—Tachycardia—Paclitaxel—lung cancer	0.00125	0.00142	CcSEcCtD
Pentazocine—Anorexia—Etoposide—lung cancer	0.00124	0.00141	CcSEcCtD
Pentazocine—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.00124	0.00141	CcSEcCtD
Pentazocine—Decreased appetite—Cisplatin—lung cancer	0.00124	0.0014	CcSEcCtD
Pentazocine—Hyperhidrosis—Paclitaxel—lung cancer	0.00124	0.0014	CcSEcCtD
Pentazocine—Anorexia—Paclitaxel—lung cancer	0.00122	0.00138	CcSEcCtD
Pentazocine—Hypotension—Etoposide—lung cancer	0.00122	0.00138	CcSEcCtD
Pentazocine—Vomiting—Vinorelbine—lung cancer	0.00121	0.00137	CcSEcCtD
Pentazocine—Dermatitis—Vinorelbine—lung cancer	0.0012	0.00136	CcSEcCtD
Pentazocine—Hypotension—Paclitaxel—lung cancer	0.0012	0.00136	CcSEcCtD
Pentazocine—Headache—Vinorelbine—lung cancer	0.00119	0.00135	CcSEcCtD
Pentazocine—Syncope—Docetaxel—lung cancer	0.00119	0.00135	CcSEcCtD
Pentazocine—Eosinophilia—Doxorubicin—lung cancer	0.00118	0.00134	CcSEcCtD
Pentazocine—Sweating—Methotrexate—lung cancer	0.00118	0.00133	CcSEcCtD
Pentazocine—Feeling abnormal—Cisplatin—lung cancer	0.00117	0.00133	CcSEcCtD
Pentazocine—Paraesthesia—Etoposide—lung cancer	0.00117	0.00133	CcSEcCtD
Pentazocine—Loss of consciousness—Docetaxel—lung cancer	0.00117	0.00132	CcSEcCtD
Pentazocine—Dyspnoea—Etoposide—lung cancer	0.00116	0.00132	CcSEcCtD
Pentazocine—Somnolence—Etoposide—lung cancer	0.00116	0.00132	CcSEcCtD
Pentazocine—Insomnia—Paclitaxel—lung cancer	0.00116	0.00131	CcSEcCtD
Pentazocine—Hypersensitivity—Irinotecan—lung cancer	0.00116	0.00131	CcSEcCtD
Pentazocine—Paraesthesia—Paclitaxel—lung cancer	0.00115	0.0013	CcSEcCtD
Pentazocine—Hypertension—Docetaxel—lung cancer	0.00115	0.0013	CcSEcCtD
Pentazocine—Agranulocytosis—Methotrexate—lung cancer	0.00114	0.0013	CcSEcCtD
Pentazocine—Dyspnoea—Paclitaxel—lung cancer	0.00114	0.00129	CcSEcCtD
Pentazocine—Somnolence—Paclitaxel—lung cancer	0.00114	0.00129	CcSEcCtD
Pentazocine—Decreased appetite—Etoposide—lung cancer	0.00113	0.00129	CcSEcCtD
Pentazocine—Nausea—Vinorelbine—lung cancer	0.00113	0.00128	CcSEcCtD
Pentazocine—Asthenia—Irinotecan—lung cancer	0.00113	0.00128	CcSEcCtD
Pentazocine—Constipation—Etoposide—lung cancer	0.00112	0.00127	CcSEcCtD
Pentazocine—Decreased appetite—Paclitaxel—lung cancer	0.00111	0.00126	CcSEcCtD
Pentazocine—Dry mouth—Docetaxel—lung cancer	0.00111	0.00125	CcSEcCtD
Pentazocine—Asthenia—Gemcitabine—lung cancer	0.0011	0.00124	CcSEcCtD
Pentazocine—Constipation—Paclitaxel—lung cancer	0.00109	0.00124	CcSEcCtD
Pentazocine—Confusional state—Docetaxel—lung cancer	0.00109	0.00124	CcSEcCtD
Pentazocine—Anaphylactic shock—Docetaxel—lung cancer	0.00108	0.00123	CcSEcCtD
Pentazocine—Pruritus—Gemcitabine—lung cancer	0.00108	0.00123	CcSEcCtD
Pentazocine—Feeling abnormal—Etoposide—lung cancer	0.00108	0.00122	CcSEcCtD
Pentazocine—Diarrhoea—Irinotecan—lung cancer	0.00107	0.00122	CcSEcCtD
Pentazocine—Shock—Docetaxel—lung cancer	0.00107	0.00121	CcSEcCtD
Pentazocine—Visual impairment—Methotrexate—lung cancer	0.00106	0.0012	CcSEcCtD
Pentazocine—Tachycardia—Docetaxel—lung cancer	0.00106	0.0012	CcSEcCtD
Pentazocine—Feeling abnormal—Paclitaxel—lung cancer	0.00105	0.0012	CcSEcCtD
Pentazocine—Hypersensitivity—Cisplatin—lung cancer	0.00105	0.00119	CcSEcCtD
Pentazocine—Diarrhoea—Gemcitabine—lung cancer	0.00105	0.00119	CcSEcCtD
Pentazocine—Erythema multiforme—Methotrexate—lung cancer	0.00104	0.00118	CcSEcCtD
Pentazocine—Dizziness—Irinotecan—lung cancer	0.00104	0.00118	CcSEcCtD
Pentazocine—Anorexia—Docetaxel—lung cancer	0.00103	0.00117	CcSEcCtD
Pentazocine—Tinnitus—Methotrexate—lung cancer	0.00103	0.00116	CcSEcCtD
Pentazocine—Asthenia—Cisplatin—lung cancer	0.00102	0.00116	CcSEcCtD
Pentazocine—Sweating—Doxorubicin—lung cancer	0.00102	0.00115	CcSEcCtD
Pentazocine—Hypotension—Docetaxel—lung cancer	0.00101	0.00115	CcSEcCtD
Pentazocine—Vomiting—Irinotecan—lung cancer	0.000998	0.00113	CcSEcCtD
Pentazocine—Agranulocytosis—Doxorubicin—lung cancer	0.00099	0.00112	CcSEcCtD
Pentazocine—Dermatitis—Irinotecan—lung cancer	0.000988	0.00112	CcSEcCtD
Pentazocine—Chills—Methotrexate—lung cancer	0.000987	0.00112	CcSEcCtD
Pentazocine—Headache—Irinotecan—lung cancer	0.000983	0.00111	CcSEcCtD
Pentazocine—Insomnia—Docetaxel—lung cancer	0.000981	0.00111	CcSEcCtD
Pentazocine—Diarrhoea—Cisplatin—lung cancer	0.000975	0.00111	CcSEcCtD
Pentazocine—Paraesthesia—Docetaxel—lung cancer	0.000974	0.0011	CcSEcCtD
Pentazocine—Vomiting—Gemcitabine—lung cancer	0.000972	0.0011	CcSEcCtD
Pentazocine—Dyspnoea—Docetaxel—lung cancer	0.000967	0.0011	CcSEcCtD
Pentazocine—Somnolence—Docetaxel—lung cancer	0.000964	0.00109	CcSEcCtD
Pentazocine—Dermatitis—Gemcitabine—lung cancer	0.000963	0.00109	CcSEcCtD
Pentazocine—Hypersensitivity—Etoposide—lung cancer	0.000962	0.00109	CcSEcCtD
Pentazocine—Headache—Gemcitabine—lung cancer	0.000958	0.00109	CcSEcCtD
Pentazocine—Decreased appetite—Docetaxel—lung cancer	0.000943	0.00107	CcSEcCtD
Pentazocine—Hypersensitivity—Paclitaxel—lung cancer	0.000943	0.00107	CcSEcCtD
Pentazocine—Dysgeusia—Methotrexate—lung cancer	0.000938	0.00106	CcSEcCtD
Pentazocine—Asthenia—Etoposide—lung cancer	0.000936	0.00106	CcSEcCtD
Pentazocine—Nausea—Irinotecan—lung cancer	0.000932	0.00106	CcSEcCtD
Pentazocine—Constipation—Docetaxel—lung cancer	0.000928	0.00105	CcSEcCtD
Pentazocine—Pruritus—Etoposide—lung cancer	0.000923	0.00105	CcSEcCtD
Pentazocine—Visual impairment—Doxorubicin—lung cancer	0.000918	0.00104	CcSEcCtD
Pentazocine—Asthenia—Paclitaxel—lung cancer	0.000918	0.00104	CcSEcCtD
Pentazocine—Nausea—Gemcitabine—lung cancer	0.000908	0.00103	CcSEcCtD
Pentazocine—Vomiting—Cisplatin—lung cancer	0.000906	0.00103	CcSEcCtD
Pentazocine—Pruritus—Paclitaxel—lung cancer	0.000905	0.00103	CcSEcCtD
Pentazocine—Vision blurred—Methotrexate—lung cancer	0.000903	0.00102	CcSEcCtD
Pentazocine—Erythema multiforme—Doxorubicin—lung cancer	0.000901	0.00102	CcSEcCtD
Pentazocine—Dermatitis—Cisplatin—lung cancer	0.000897	0.00102	CcSEcCtD
Pentazocine—Feeling abnormal—Docetaxel—lung cancer	0.000894	0.00101	CcSEcCtD
Pentazocine—Diarrhoea—Etoposide—lung cancer	0.000893	0.00101	CcSEcCtD
Pentazocine—Tinnitus—Doxorubicin—lung cancer	0.000888	0.00101	CcSEcCtD
Pentazocine—Flushing—Doxorubicin—lung cancer	0.000884	0.001	CcSEcCtD
Pentazocine—Diarrhoea—Paclitaxel—lung cancer	0.000876	0.000993	CcSEcCtD
Pentazocine—Dizziness—Etoposide—lung cancer	0.000863	0.000978	CcSEcCtD
Pentazocine—Vertigo—Methotrexate—lung cancer	0.000861	0.000976	CcSEcCtD
Pentazocine—Chills—Doxorubicin—lung cancer	0.000855	0.000969	CcSEcCtD
Pentazocine—Dizziness—Paclitaxel—lung cancer	0.000846	0.000959	CcSEcCtD
Pentazocine—Nausea—Cisplatin—lung cancer	0.000846	0.000959	CcSEcCtD
Pentazocine—Vomiting—Etoposide—lung cancer	0.00083	0.000941	CcSEcCtD
Pentazocine—Dermatitis—Etoposide—lung cancer	0.000822	0.000932	CcSEcCtD
Pentazocine—Headache—Etoposide—lung cancer	0.000818	0.000927	CcSEcCtD
Pentazocine—Vomiting—Paclitaxel—lung cancer	0.000814	0.000922	CcSEcCtD
Pentazocine—Dysgeusia—Doxorubicin—lung cancer	0.000812	0.000921	CcSEcCtD
Pentazocine—Dermatitis—Paclitaxel—lung cancer	0.000806	0.000914	CcSEcCtD
Pentazocine—Headache—Paclitaxel—lung cancer	0.000802	0.000909	CcSEcCtD
Pentazocine—Hypersensitivity—Docetaxel—lung cancer	0.000799	0.000906	CcSEcCtD
Pentazocine—Muscle spasms—Doxorubicin—lung cancer	0.000797	0.000904	CcSEcCtD
Pentazocine—Confusional state—Methotrexate—lung cancer	0.000788	0.000894	CcSEcCtD
Pentazocine—Anaphylactic shock—Methotrexate—lung cancer	0.000782	0.000886	CcSEcCtD
Pentazocine—Vision blurred—Doxorubicin—lung cancer	0.000782	0.000886	CcSEcCtD
Pentazocine—Asthenia—Docetaxel—lung cancer	0.000778	0.000882	CcSEcCtD
Pentazocine—Nausea—Etoposide—lung cancer	0.000775	0.000879	CcSEcCtD
Pentazocine—Pruritus—Docetaxel—lung cancer	0.000767	0.00087	CcSEcCtD
Pentazocine—Agitation—Doxorubicin—lung cancer	0.000762	0.000864	CcSEcCtD
Pentazocine—Nausea—Paclitaxel—lung cancer	0.00076	0.000862	CcSEcCtD
Pentazocine—Hyperhidrosis—Methotrexate—lung cancer	0.000756	0.000857	CcSEcCtD
Pentazocine—Vertigo—Doxorubicin—lung cancer	0.000745	0.000845	CcSEcCtD
Pentazocine—Anorexia—Methotrexate—lung cancer	0.000745	0.000845	CcSEcCtD
Pentazocine—Syncope—Doxorubicin—lung cancer	0.000744	0.000843	CcSEcCtD
Pentazocine—Diarrhoea—Docetaxel—lung cancer	0.000742	0.000841	CcSEcCtD
Pentazocine—Hypotension—Methotrexate—lung cancer	0.00073	0.000828	CcSEcCtD
Pentazocine—Loss of consciousness—Doxorubicin—lung cancer	0.000729	0.000826	CcSEcCtD
Pentazocine—Dizziness—Docetaxel—lung cancer	0.000717	0.000813	CcSEcCtD
Pentazocine—Hypertension—Doxorubicin—lung cancer	0.000716	0.000812	CcSEcCtD
Pentazocine—Insomnia—Methotrexate—lung cancer	0.000707	0.000802	CcSEcCtD
Pentazocine—Paraesthesia—Methotrexate—lung cancer	0.000702	0.000796	CcSEcCtD
Pentazocine—Dyspnoea—Methotrexate—lung cancer	0.000697	0.00079	CcSEcCtD
Pentazocine—Somnolence—Methotrexate—lung cancer	0.000695	0.000788	CcSEcCtD
Pentazocine—Dry mouth—Doxorubicin—lung cancer	0.000691	0.000783	CcSEcCtD
Pentazocine—Vomiting—Docetaxel—lung cancer	0.00069	0.000782	CcSEcCtD
Pentazocine—Dermatitis—Docetaxel—lung cancer	0.000683	0.000775	CcSEcCtD
Pentazocine—Confusional state—Doxorubicin—lung cancer	0.000683	0.000774	CcSEcCtD
Pentazocine—Decreased appetite—Methotrexate—lung cancer	0.00068	0.00077	CcSEcCtD
Pentazocine—Headache—Docetaxel—lung cancer	0.000679	0.00077	CcSEcCtD
Pentazocine—Anaphylactic shock—Doxorubicin—lung cancer	0.000677	0.000767	CcSEcCtD
Pentazocine—Shock—Doxorubicin—lung cancer	0.000666	0.000755	CcSEcCtD
Pentazocine—Tachycardia—Doxorubicin—lung cancer	0.000661	0.000749	CcSEcCtD
Pentazocine—Hyperhidrosis—Doxorubicin—lung cancer	0.000654	0.000742	CcSEcCtD
Pentazocine—Anorexia—Doxorubicin—lung cancer	0.000645	0.000731	CcSEcCtD
Pentazocine—Nausea—Docetaxel—lung cancer	0.000644	0.00073	CcSEcCtD
Pentazocine—Feeling abnormal—Methotrexate—lung cancer	0.000644	0.00073	CcSEcCtD
Pentazocine—Hypotension—Doxorubicin—lung cancer	0.000633	0.000717	CcSEcCtD
Pentazocine—Insomnia—Doxorubicin—lung cancer	0.000612	0.000694	CcSEcCtD
Pentazocine—Paraesthesia—Doxorubicin—lung cancer	0.000608	0.000689	CcSEcCtD
Pentazocine—Dyspnoea—Doxorubicin—lung cancer	0.000604	0.000684	CcSEcCtD
Pentazocine—Somnolence—Doxorubicin—lung cancer	0.000602	0.000682	CcSEcCtD
Pentazocine—Decreased appetite—Doxorubicin—lung cancer	0.000588	0.000667	CcSEcCtD
Pentazocine—Constipation—Doxorubicin—lung cancer	0.000579	0.000656	CcSEcCtD
Pentazocine—Hypersensitivity—Methotrexate—lung cancer	0.000576	0.000653	CcSEcCtD
Pentazocine—Asthenia—Methotrexate—lung cancer	0.000561	0.000636	CcSEcCtD
Pentazocine—Feeling abnormal—Doxorubicin—lung cancer	0.000558	0.000632	CcSEcCtD
Pentazocine—Pruritus—Methotrexate—lung cancer	0.000553	0.000627	CcSEcCtD
Pentazocine—Diarrhoea—Methotrexate—lung cancer	0.000535	0.000606	CcSEcCtD
Pentazocine—Dizziness—Methotrexate—lung cancer	0.000517	0.000586	CcSEcCtD
Pentazocine—Hypersensitivity—Doxorubicin—lung cancer	0.000499	0.000565	CcSEcCtD
Pentazocine—Vomiting—Methotrexate—lung cancer	0.000497	0.000563	CcSEcCtD
Pentazocine—Dermatitis—Methotrexate—lung cancer	0.000492	0.000558	CcSEcCtD
Pentazocine—Headache—Methotrexate—lung cancer	0.00049	0.000555	CcSEcCtD
Pentazocine—Asthenia—Doxorubicin—lung cancer	0.000486	0.000551	CcSEcCtD
Pentazocine—Pruritus—Doxorubicin—lung cancer	0.000479	0.000543	CcSEcCtD
Pentazocine—Nausea—Methotrexate—lung cancer	0.000464	0.000526	CcSEcCtD
Pentazocine—Diarrhoea—Doxorubicin—lung cancer	0.000463	0.000525	CcSEcCtD
Pentazocine—Dizziness—Doxorubicin—lung cancer	0.000448	0.000507	CcSEcCtD
Pentazocine—Vomiting—Doxorubicin—lung cancer	0.00043	0.000488	CcSEcCtD
Pentazocine—Dermatitis—Doxorubicin—lung cancer	0.000426	0.000483	CcSEcCtD
Pentazocine—Headache—Doxorubicin—lung cancer	0.000424	0.000481	CcSEcCtD
Pentazocine—Nausea—Doxorubicin—lung cancer	0.000402	0.000456	CcSEcCtD
Pentazocine—OPRK1—Signaling Pathways—PPP2R1B—lung cancer	8.62e-05	0.000803	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FLT1—lung cancer	8.54e-05	0.000795	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CG—lung cancer	8.46e-05	0.000788	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOTCH3—lung cancer	8.36e-05	0.000778	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APP—lung cancer	8.36e-05	0.000778	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HSPB1—lung cancer	8.32e-05	0.000774	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GNG11—lung cancer	8.32e-05	0.000774	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGF9—lung cancer	8.29e-05	0.000772	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTHLH—lung cancer	8.23e-05	0.000766	CbGpPWpGaD
Pentazocine—OPRM1—GPCR ligand binding—CXCL8—lung cancer	8.17e-05	0.000761	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AVP—lung cancer	8.16e-05	0.000759	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—POMC—lung cancer	8.05e-05	0.00075	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFC—lung cancer	7.92e-05	0.000737	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JUNB—lung cancer	7.92e-05	0.000737	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ANXA1—lung cancer	7.73e-05	0.00072	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CG—lung cancer	7.68e-05	0.000715	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FLT1—lung cancer	7.49e-05	0.000697	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADCY1—lung cancer	7.48e-05	0.000696	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CD—lung cancer	7.44e-05	0.000692	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CG—lung cancer	7.42e-05	0.000691	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOTCH3—lung cancer	7.33e-05	0.000682	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APP—lung cancer	7.33e-05	0.000682	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—POMC—lung cancer	7.31e-05	0.000681	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PPP2R1B—lung cancer	7.29e-05	0.000678	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SMARCA4—lung cancer	7.29e-05	0.000678	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGF9—lung cancer	7.27e-05	0.000677	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STK11—lung cancer	7.19e-05	0.000669	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6R—lung cancer	7.14e-05	0.000664	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—POMC—lung cancer	7.06e-05	0.000657	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HSPB1—lung cancer	7.03e-05	0.000654	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTHLH—lung cancer	6.95e-05	0.000647	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JUNB—lung cancer	6.94e-05	0.000646	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FOXO3—lung cancer	6.94e-05	0.000646	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MAP2K1—lung cancer	6.8e-05	0.000633	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CD—lung cancer	6.76e-05	0.000629	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CG—lung cancer	6.74e-05	0.000627	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ANXA1—lung cancer	6.54e-05	0.000608	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CD—lung cancer	6.52e-05	0.000607	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AVP—lung cancer	6.5e-05	0.000605	CbGpPWpGaD
Pentazocine—EBP—Metabolism—PIK3CA—lung cancer	6.5e-05	0.000605	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CB—lung cancer	6.48e-05	0.000604	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—POMC—lung cancer	6.41e-05	0.000597	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FLT1—lung cancer	6.33e-05	0.000589	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STK11—lung cancer	6.3e-05	0.000587	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CG—lung cancer	6.27e-05	0.000584	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF1R—lung cancer	6.26e-05	0.000583	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6R—lung cancer	6.26e-05	0.000582	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL8—lung cancer	6.23e-05	0.00058	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APP—lung cancer	6.2e-05	0.000577	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOTCH3—lung cancer	6.2e-05	0.000577	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HES1—lung cancer	6.15e-05	0.000572	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGF9—lung cancer	6.15e-05	0.000572	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FOXO3—lung cancer	6.08e-05	0.000566	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—RAF1—lung cancer	6.03e-05	0.000561	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—POMC—lung cancer	5.97e-05	0.000556	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAP2K1—lung cancer	5.96e-05	0.000555	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—IL2—lung cancer	5.95e-05	0.000554	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CD—lung cancer	5.92e-05	0.000551	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CB—lung cancer	5.89e-05	0.000548	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JUNB—lung cancer	5.87e-05	0.000546	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AVP—lung cancer	5.7e-05	0.000531	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CG—lung cancer	5.69e-05	0.00053	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CB—lung cancer	5.69e-05	0.000529	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL8—lung cancer	5.66e-05	0.000527	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ERBB3—lung cancer	5.62e-05	0.000523	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CD—lung cancer	5.51e-05	0.000513	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF1R—lung cancer	5.49e-05	0.000511	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL8—lung cancer	5.46e-05	0.000509	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—POMC—lung cancer	5.42e-05	0.000505	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL2—lung cancer	5.41e-05	0.000503	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HES1—lung cancer	5.39e-05	0.000502	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TERT—lung cancer	5.39e-05	0.000502	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STK11—lung cancer	5.33e-05	0.000496	CbGpPWpGaD
Pentazocine—EBP—Metabolism—AKT1—lung cancer	5.31e-05	0.000494	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—RAF1—lung cancer	5.29e-05	0.000492	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6R—lung cancer	5.29e-05	0.000492	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGFR1—lung cancer	5.23e-05	0.000487	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—IL2—lung cancer	5.22e-05	0.000486	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CB—lung cancer	5.16e-05	0.000481	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HIF1A—lung cancer	5.15e-05	0.00048	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FOXO3—lung cancer	5.14e-05	0.000479	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAP2K1—lung cancer	5.04e-05	0.000469	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CD—lung cancer	5.01e-05	0.000466	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOA1—lung cancer	4.97e-05	0.000463	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL8—lung cancer	4.96e-05	0.000462	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ERBB3—lung cancer	4.93e-05	0.000459	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KDR—lung cancer	4.93e-05	0.000459	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AVP—lung cancer	4.82e-05	0.000449	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CB—lung cancer	4.81e-05	0.000447	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL2—lung cancer	4.74e-05	0.000441	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TERT—lung cancer	4.72e-05	0.00044	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF1R—lung cancer	4.64e-05	0.000432	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL8—lung cancer	4.62e-05	0.00043	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGFR1—lung cancer	4.59e-05	0.000427	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HES1—lung cancer	4.56e-05	0.000424	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APC—lung cancer	4.54e-05	0.000423	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CG—lung cancer	4.54e-05	0.000423	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KIT—lung cancer	4.54e-05	0.000423	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—NRAS—lung cancer	4.54e-05	0.000423	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HIF1A—lung cancer	4.52e-05	0.000421	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EGF—lung cancer	4.49e-05	0.000418	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—RAF1—lung cancer	4.47e-05	0.000416	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—IL2—lung cancer	4.41e-05	0.000411	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CB—lung cancer	4.36e-05	0.000406	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOA1—lung cancer	4.36e-05	0.000406	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—MAPK3—lung cancer	4.35e-05	0.000405	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KDR—lung cancer	4.32e-05	0.000402	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—POMC—lung cancer	4.32e-05	0.000402	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—BRAF—lung cancer	4.27e-05	0.000397	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6R—lung cancer	4.22e-05	0.000392	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CREBBP—lung cancer	4.21e-05	0.000392	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL8—lung cancer	4.19e-05	0.00039	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ERBB3—lung cancer	4.17e-05	0.000388	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—EGFR—lung cancer	4.14e-05	0.000385	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAP2K1—lung cancer	4.02e-05	0.000374	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL2—lung cancer	4.01e-05	0.000373	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TERT—lung cancer	3.99e-05	0.000372	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CD—lung cancer	3.99e-05	0.000371	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KIT—lung cancer	3.98e-05	0.000371	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APC—lung cancer	3.98e-05	0.000371	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CG—lung cancer	3.98e-05	0.000371	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—NRAS—lung cancer	3.98e-05	0.000371	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—PIK3CA—lung cancer	3.95e-05	0.000368	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EGF—lung cancer	3.93e-05	0.000366	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—KRAS—lung cancer	3.91e-05	0.000364	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGFR1—lung cancer	3.88e-05	0.000361	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HIF1A—lung cancer	3.82e-05	0.000355	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—MAPK3—lung cancer	3.81e-05	0.000355	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—POMC—lung cancer	3.79e-05	0.000353	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—BRAF—lung cancer	3.74e-05	0.000348	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6R—lung cancer	3.7e-05	0.000344	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CREBBP—lung cancer	3.69e-05	0.000344	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOA1—lung cancer	3.68e-05	0.000343	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KDR—lung cancer	3.65e-05	0.00034	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—EGFR—lung cancer	3.63e-05	0.000338	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—PIK3CA—lung cancer	3.59e-05	0.000334	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MDM2—lung cancer	3.58e-05	0.000333	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RAF1—lung cancer	3.56e-05	0.000332	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ERBB2—lung cancer	3.52e-05	0.000328	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAP2K1—lung cancer	3.52e-05	0.000328	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CD—lung cancer	3.5e-05	0.000326	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MTOR—lung cancer	3.48e-05	0.000324	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CB—lung cancer	3.48e-05	0.000324	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3CA—lung cancer	3.47e-05	0.000323	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—KRAS—lung cancer	3.43e-05	0.000319	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APC—lung cancer	3.36e-05	0.000313	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KIT—lung cancer	3.36e-05	0.000313	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CG—lung cancer	3.36e-05	0.000313	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—NRAS—lung cancer	3.36e-05	0.000313	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL8—lung cancer	3.34e-05	0.000311	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EGF—lung cancer	3.33e-05	0.00031	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—HRAS—lung cancer	3.32e-05	0.000309	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AKT1—lung cancer	3.23e-05	0.000301	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—MAPK3—lung cancer	3.22e-05	0.0003	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—POMC—lung cancer	3.2e-05	0.000298	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CASP3—lung cancer	3.2e-05	0.000298	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL2—lung cancer	3.19e-05	0.000297	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—lung cancer	3.18e-05	0.000296	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—BRAF—lung cancer	3.16e-05	0.000294	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3CA—lung cancer	3.15e-05	0.000293	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MDM2—lung cancer	3.13e-05	0.000292	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RAF1—lung cancer	3.12e-05	0.000291	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6R—lung cancer	3.12e-05	0.000291	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CREBBP—lung cancer	3.12e-05	0.00029	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCND1—lung cancer	3.11e-05	0.00029	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—JUN—lung cancer	3.11e-05	0.000289	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ERBB2—lung cancer	3.09e-05	0.000288	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—EGFR—lung cancer	3.06e-05	0.000285	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CB—lung cancer	3.05e-05	0.000284	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MTOR—lung cancer	3.05e-05	0.000284	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP9—lung cancer	3.02e-05	0.000281	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CDKN1A—lung cancer	3.01e-05	0.00028	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTEN—lung cancer	3.01e-05	0.00028	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAP2K1—lung cancer	2.98e-05	0.000277	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CD—lung cancer	2.96e-05	0.000275	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT1—lung cancer	2.93e-05	0.000273	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL8—lung cancer	2.93e-05	0.000273	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	2.93e-05	0.000273	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—HRAS—lung cancer	2.91e-05	0.000271	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—KRAS—lung cancer	2.9e-05	0.00027	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EP300—lung cancer	2.87e-05	0.000267	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AKT1—lung cancer	2.83e-05	0.000264	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CASP3—lung cancer	2.81e-05	0.000261	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL2—lung cancer	2.8e-05	0.000261	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SRC—lung cancer	2.79e-05	0.000259	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—lung cancer	2.79e-05	0.000259	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCND1—lung cancer	2.73e-05	0.000254	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—JUN—lung cancer	2.72e-05	0.000254	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VEGFA—lung cancer	2.71e-05	0.000253	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—STAT3—lung cancer	2.69e-05	0.00025	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NRAS—lung cancer	2.68e-05	0.00025	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	2.66e-05	0.000248	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP9—lung cancer	2.65e-05	0.000247	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MDM2—lung cancer	2.65e-05	0.000247	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDKN1A—lung cancer	2.64e-05	0.000246	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RAF1—lung cancer	2.64e-05	0.000246	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTEN—lung cancer	2.64e-05	0.000245	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ERBB2—lung cancer	2.61e-05	0.000243	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MTOR—lung cancer	2.58e-05	0.00024	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CB—lung cancer	2.58e-05	0.00024	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT1—lung cancer	2.57e-05	0.000239	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK3—lung cancer	2.57e-05	0.000239	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EP300—lung cancer	2.51e-05	0.000234	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MYC—lung cancer	2.5e-05	0.000233	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL8—lung cancer	2.48e-05	0.000231	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—HRAS—lung cancer	2.46e-05	0.000229	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SRC—lung cancer	2.44e-05	0.000228	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EGFR—lung cancer	2.44e-05	0.000227	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT1—lung cancer	2.39e-05	0.000223	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VEGFA—lung cancer	2.38e-05	0.000222	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CASP3—lung cancer	2.37e-05	0.000221	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL2—lung cancer	2.37e-05	0.00022	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—STAT3—lung cancer	2.36e-05	0.000219	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—lung cancer	2.36e-05	0.000219	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NRAS—lung cancer	2.35e-05	0.000219	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KRAS—lung cancer	2.31e-05	0.000215	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCND1—lung cancer	2.31e-05	0.000215	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—JUN—lung cancer	2.3e-05	0.000214	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK3—lung cancer	2.25e-05	0.00021	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP9—lung cancer	2.24e-05	0.000209	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDKN1A—lung cancer	2.23e-05	0.000208	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTEN—lung cancer	2.23e-05	0.000207	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MYC—lung cancer	2.19e-05	0.000204	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT1—lung cancer	2.17e-05	0.000202	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EGFR—lung cancer	2.14e-05	0.000199	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EP300—lung cancer	2.12e-05	0.000198	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3CA—lung cancer	2.12e-05	0.000197	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SRC—lung cancer	2.07e-05	0.000192	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TP53—lung cancer	2.05e-05	0.000191	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KRAS—lung cancer	2.02e-05	0.000188	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFA—lung cancer	2.01e-05	0.000187	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STAT3—lung cancer	1.99e-05	0.000185	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NRAS—lung cancer	1.99e-05	0.000185	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HRAS—lung cancer	1.96e-05	0.000183	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK3—lung cancer	1.9e-05	0.000177	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—lung cancer	1.88e-05	0.000175	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3CA—lung cancer	1.86e-05	0.000173	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MYC—lung cancer	1.85e-05	0.000172	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EGFR—lung cancer	1.81e-05	0.000169	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TP53—lung cancer	1.8e-05	0.000167	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT1—lung cancer	1.73e-05	0.000161	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HRAS—lung cancer	1.72e-05	0.00016	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KRAS—lung cancer	1.71e-05	0.000159	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—lung cancer	1.65e-05	0.000153	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3CA—lung cancer	1.57e-05	0.000146	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TP53—lung cancer	1.52e-05	0.000142	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT1—lung cancer	1.52e-05	0.000141	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HRAS—lung cancer	1.45e-05	0.000135	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—lung cancer	1.39e-05	0.00013	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT1—lung cancer	1.28e-05	0.000119	CbGpPWpGaD
